Acne or acne vulgaris is a skin condition characterized by the clogging of hair follicles with dead skin cells. It is mostly seen in teenagers. It has affected the skin with the highest number of oil glands. The global acne treatment market report by Market Research Future (MRFR) consists of drivers, challenges, trends, and opportunities for the period of 2018 to 2023 (forecast period). The impact of the COVID-19 virus on the industry has been discussed.

The global acne treatment market size is expected to grow at an approximate CAGR of 5.3% during the forecast period. Its prevalence among teenagers is likely to drive its demand. Factors promoting acne growth are excessive sebum production, shedding of dead skin, bacterial growth, and inflammation and immune system response. Societal standards for fairness and clear skin as well as its effect on the psyche of individuals are influencing the market growth.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/5675

Development of anti-acne cosmetics and the high spending of individuals on clearing of skin can provide new growth opportunities for the market. In 2016, the Americans had spend more than USD 1.5 billion on aesthetic procedures.

Competitive Outlook

Bayer AG, Roche Holding AG, Stiefel Laboratories, Inc., Valeant, Teva Pharmaceutical Industries Ltd., ALLERGAN, Galderma S.A., Johnson & Johnson Services, Inc., and GlaxoSmithKline Plc. are key players of the global acne treatment market.

Segmentation

The global acne treatment market is segmented based on type, treatment, treatment modality, and end users.

Based on the Type, the acne treatment market is segmented into cystic acne, comedonal acne, inflammatory acne, post surgical/wound acne, and others.
Based on Treatment, the acne treatment market is categorized into medication, therapeutic devices, and others. The medication segment is-sub segmented into antibiotics, retinoid, and others. The retinoid segment is further segmented into tretinoin, adapalene, others. The antibiotics segment is further segmented into erythromycin, clindamycin, and others. The therapeutic devices segment is sub-segmented into dermabradors, lasers, microdermabrader, and others.
Based on Treatment Modality, the acne treatment market is segmented into oral, topical, injectable.
Based on End users, the acne treatment market is segmented into ambulatory surgical centers, hospitals & clinics, pharmacies & drug stores, and others.
Regional Analysis

The Americas dominates the global acne treatment market. Factors driving market growth are well-developed healthcare sector and a huge patient population. Moreover, change in lifestyle and spending on cosmetic surgery has boosted the growth of the acne treatment market within the region. The spending power of teenagers and adults in the U.S. and Canada within the region fuels the acne treatment market growth.

Europe has assumed the second position in the global acne treatment market and is followed by APAC. Ample availability of funds for research, a huge patient pool, and increasing teenage population are major drivers of the market within the region. According to Eurostat in 2014, there were approximately 507 million inhabitants within the region. Amongst this population, about 79 million accounted for children aging up to 14 years.

Get Access Full Report @ https://www.marketresearchfuture.com/reports/acne-treatment-market-5675

APAC is projected to be the fastest growing region for the market due to increasing prevalence of acne, and spending power of adults and teens in developing economies of India and China within the region. The region exports the maximum acne topical treatment medicines to North America and Europe owing to presence of major pharmaceutical players. According to the Indian Journal of Paediatric Dermatology in 2017, about 200 million to 300 million people in India were estimated to be afflicted with acne.